Stockscreener 앱 받기
118.65
1.46%
-1.76
시간 외 거래:
118.34
-0.31
-0.26%
전일 마감가:
$120.41
열려 있는:
$120.79
하루 거래량:
4.27M
Relative Volume:
1.13
시가총액:
$52.29B
수익:
$9.40B
순이익/손실:
$2.65B
주가수익비율:
19.99
EPS:
5.935
순현금흐름:
$2.24B
1주 성능:
-7.43%
1개월 성능:
-1.53%
6개월 성능:
-29.63%
1년 성능:
-32.11%
1일 변동 폭
$118.47
$121.33
1주일 범위
$118.47
$129.58
52주 변동 폭
$115.25
$181.85
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
ZTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
118.65 | 53.06B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.18 | 45.11B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.44B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.46 | 32.59B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
489.31 | 20.84B | 3.08B | 1.24B | 1.07B | 25.61 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Animal Vaccines Market Top key Players 2035 | Vetoquinol, Heska - openPR.com
Edgestream Partners L.P. Has $1.73 Million Stake in Zoetis Inc. $ZTS - MarketBeat
Amundi Has $439.04 Million Stake in Zoetis Inc. $ZTS - MarketBeat
1832 Asset Management L.P. Acquires 9,472 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zoetis (ZTS) Gains Health Canada Approval for New Cat Osteoarthritis Treatment - GuruFocus
EBIT per share of Zoetis, Inc. Class A – GETTEX:ZOE - TradingView
Zoetis Says Health Canada Approves Long-Lasting Cat Osteoarthritis Drug - marketscreener.com
Zoetis receives Health Canada approval for feline arthritis therapy By Investing.com - Investing.com Australia
Zoetis receives Health Canada approval for feline arthritis therapy - Investing.com
Earnings are growing at Zoetis (NYSE:ZTS) but shareholders still don't like its prospects - Yahoo Finance
Zoetis receives Health Canada approval for Portela (Relfovetmab injection) - marketscreener.com
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats - Bakersfield.com
Invesco Ltd. Buys 468,173 Shares of Zoetis Inc. $ZTS - MarketBeat
Is Zoetis Inc. (ZOE) stock bottoming after sell offEarnings Recap Summary & Entry Point Confirmation Signals - Newser
Panagora Asset Management Inc. Sells 8,834 Shares of Zoetis Inc. $ZTS - MarketBeat
Why Zoetis Inc. (ZOE) stock stays on top picksJuly 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
Epoch Investment Partners Inc. Sells 187,530 Shares of Zoetis Inc. $ZTS - MarketBeat
Brown Advisory Inc. Purchases 250,829 Shares of Zoetis Inc. $ZTS - MarketBeat
Baird Financial Group Inc. Decreases Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Is Zoetis Inc. Class stock a momentum leaderPortfolio Return Report & Fast Gain Swing Trade Alerts - Newser
Zoetis Inc. (NYSE:ZTS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Is Zoetis Inc. (ZOE) stock a buy before earnings resultsOil Prices & Weekly Watchlist for Consistent Profits - Newser
Zoetis (ZTS) Up 1.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Transcript : Zoetis Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-04-2025 09 - marketscreener.com
Zoetis Inc. (ZTS): A bull case theory - MSN
Zoetis Inc. (ZTS): A Bull Case Theory - Insider Monkey
Zoetis Stock Plummets 24.8% YTD: Here's What You Need to Know - Nasdaq
BTIG Research Reiterates "Buy" Rating for Zoetis (NYSE:ZTS) - MarketBeat
Schroder Investment Management Group Decreases Holdings in Zoetis Inc. $ZTS - MarketBeat
Quantbot Technologies LP Sells 25,551 Shares of Zoetis Inc. $ZTS - MarketBeat
Why Zoetis Inc. Class stock is a strong analyst pick2025 Price Targets & AI Driven Stock Movement Reports - Newser
Zoetis Inc. $ZTS Shares Bought by Guggenheim Capital LLC - MarketBeat
TD Cowen Adjusts Zoetis Price Target to $150 From $189, Maintains Buy Rating - marketscreener.com
Westerkirk Capital Inc. Invests $5.26 Million in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Position Reduced by M&T Bank Corp - MarketBeat
OMERS ADMINISTRATION Corp Buys 10,500 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Positioned for Long-Term Growth with Strategic Market Expansion and Innovative Product Launches - TipRanks
Rothschild & Co Redburn Adjusts Price Target on Zoetis to $165 From $195, Maintains Buy Rating - MarketScreener
Lido Advisors LLC Purchases 9,444 Shares of Zoetis Inc. $ZTS - MarketBeat
BTIG Reiterates Buy Rating for Zoetis (ZTS) with $160 Target Pri - GuruFocus
BTIG reiterates Buy rating on Zoetis stock after Innovation Day By Investing.com - Investing.com Nigeria
BTIG reiterates Buy rating on Zoetis stock after Innovation Day - Investing.com
Groupe la Francaise Acquires 21,534 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast - lelezard.com
Zoetis Inc. $ZTS Shares Purchased by Arrowstreet Capital Limited Partnership - MarketBeat
Zoetis (NYSE: ZTS) director Form 3 shows no current share or option holdings - Stock Titan
Zoetis Inc. (ZTS) Announces Upcoming Innovation Webcast - GuruFocus
Zoetis Hosts Innovation Webcast on Animal Health - MSN
Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health InnovationSlideshow - Seeking Alpha
Zoetis Inc.: Revenue and Earnings Analysts Forecasts Revisions | ZTS | US98978V1035 - marketscreener.com
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.70%
0.18%
자본화:
|
볼륨(24시간):